ALK and inflammatory myofibroblastic tumor: Numerous ALK fusion proteins have been described in a wide range of cancers including non-small-cell-lung-cancer (NSCLC), inflammatory immunofibroblastic tumors (IMT), and diffuse B cell lymphoma (DBCL) (8).